Common and Specific Information From Neuroimaging and Smartphone

NCT05482906 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-03-13

No results posted yet for this study

Summary

Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).

Conditions

Interventions

OTHER

eGait

IMU sensor (as part of eGait device) worn at the hip during T25FW

Sponsors & Collaborators

  • Rennes University Hospital

    collaborator OTHER
  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-03
Primary Completion
2026-04-30
Completion
2026-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05482906 on ClinicalTrials.gov